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Summary: A Spectrophotometric method is described for the determination of 5'-nucleotidase.
In combination with the enzymes nucleoside phosphorylase and xanthine oxidase, inosine, formed by hydrolysis of
S'-IMP by S'-nucleotidase, is cleaved phosphorolytically to hypoxanthine, which is oxidized to uric acid. In the
presence of ethanol, the hydrogen peroxide formed is reduced by catalase and equivalent amounts of acetaldehyde
are produced. The aldehyde is dehydrogenated (NADP-dependent) by aldehyde dehydrogenase and the production
ι rate of NADPH is recorded at 334 nm. The inhibition of the unspecific cleavage of 5'-IMP by phosphatases is examined
critically.
Eine neue spektrophotometrische Methode zur Bestimmung von 5'-Nucleotidasel
Zusammenfassung: Eine spektrophotometrische Methode f r die Bestimmung der S'-Nucleotidaseaktivit t wird be-
! schrieben.
; In Kombination mit den Enzymen Nucleosidphosphorylase und Xanthinoxidase wird Inosin, das bei der Hydrolyse
i von S'-IMP durch die S'-Nucleotidase entsteht, phosphorolytisch zu Hypoxanthin gespalten, das weiter zu Harns ure
j oxidiert wird. Das entstandene Wasserstoffperoxid wird mit Katalase in Gegenwart von Ethanol reduziert. Dabei ent-
! stehen quimol fe Mengen an Acetaldehyd. Der Aldehyd wird NADP-abh ngig durch die Aldehyddehydrogenase
l dehydriert und das gebildete NADPH bei 334 nm automatisch registriert. Die Inhibierung der unspezifischen S'-IMP-
} Hydrolyse wird kritisch untersucht.
Introduction marker for liver disease (1). Elevated enzyme levels
<j, are detectable in sera particularly if the hepatobiliary
S'-nucleotidases catalyze the hydrolysis of nucleoside.5 * ^ .$ ^ ^, generallyj the rise in S'-nucleotidase
monophosphates to nucleosides and inorganic phosphate.
 actMty is accompanied by that of alkaline phosphatase,
5'=nueleotidase activity has been detected in a great glutamyltransferase and other marker enzymes for
number of human and animal tissues (1, 2). liver disease. However, alkaline phosphatase is also
elevated in some bone diseases and during normal
. . . . ... . ιΑβΟΑ r n a n v rom e
actmty present m serais re^ey p^ancy, whereas S'-nucleotidase remains unaltered
membrane of bver ceUs by bde salts and can be used as P
 conditions (J)
The diagnostic value of S'-nucleotidase is still under
*> This work contains part of the dissertation of Renate PUz, discussion, but the enzyme has been shown to be
Ρ^^β^ΐα^ΑΑοΜ Meeting on Enzy- superior to other liver enzymes, especially in cases of
mes, Dubrovnik-Cavtat 1979. liver metastasis (1, 3,4, 5).
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For the determination of 5'-nucleotidase activity, the
following methods have been described:
For the detection of especially low activities, radio-
active methods with 14C, 3H and 32P labelled
nucleoside-S'-monophosphates, particularly 5 '-AMP,
are used, but special equipment is needed (6, 7, 8).
One of the oldest methods uses the determination of
inorganic phosphate liberated from the substrate
according to Fiske-Subbarow (9, 10). This method has
been adapted to automation (11) and modified by
several authors (12, 13, 14, 15).
With 5'-AMP as substrate, the reaction product
adenosine can be deaminated to inosine by coupling
with the adenosine deaminase reaction, and the dis-
appearance of adenosine is measured at 265 nm (8, 16,
17, 18). The ammonia formation can be determined
by the Berthelot reaction (19, 20, 21, 22, 23) or
kinetically by coupling with the glutamate dehydrogen-
ase reaction (24, 25, 26, 27, 28).
Considerable problems occur with the high absorbances
of the substrate and the serum samples at 265 nm, and
the high blanks caused by ammonia normally present in
sera.
With 5 '-IMP as the substrate, the reaction product
inosine can be converted to urate by the coupled
nucleoside phosphorylase and xanthine oxidase reac-
tions which may be monitored at 293 nm (29), but at
this wavelength, the serum samples exhibit high ab-
sorbances.
We describe a simple kinetic assay with 5 '-IMP as the
substrate, using the following reaction sequence:
/ i \ · · r' n , TT r\(1) mosme-5 -P + H20 S'-nucleotidase . .inosine
,-N .(2) inosine +
nucleoside
phosphorylase .
> hypoxanthme
+ ribose-1-P
xanthine
(3) hypoxanthine + 2H20 + 202 °X' ase > uric acid
+ 2H202
(3) 2H202 + 2 ethanol ***) 2 acetaldehyde +4H20
(5) 2 acetaldehyde
Sum:
inosine-5'-P + 2NADP+
+ 2 ethanol + 2 02
aldehyde
dehydrogenase 2 acetic acid
"" +2NADPH
+2H+
uric acid + ribose-1-P
+ 2 acetic acid
+ 2NADPH + 2H+
later for the measurement of several other substances
(32) and enzymes of purine metabolism.(33, 34).
A special problem of 5'-micleotidase assay derives from
the interference of alkaline phosphatase. Different
possibilities for the elimination of this interference are
analyzed critically.
Materials and Methods
Sera
Sera were used from patients with liver diseases (containing high
5'-nucleotidase and high alkaline phosphatase activities), from
patients with bone disease, and from healthy persons. All sera
were stored overnight at 4 °C.
Reagents
Stock solutions
NADP (Boehringer Mannheim 128031; 12 mmol/1): 10 mg were
dissolved in 1 ml bidist. water.
NAD (Boehringer Mannheim 127302; 15 mmol/1): 10 mg were
dissolved in 1 ml bidist. water.
Magnesium chloride (Merck 5833): 1 mol/1.
Manganese-II-chloride (Merck 5927): 1 mol/1.
Glycerpl-2-phosphate (disodium salt, Sigma G-6521): 1 mol/l,
adjusted to pH 7.5.
R 823l2) (Janssen, Düsseldorf): 33.9 mg were dissolved in 1 ml
0.1 mol/1 triethanolamine buffer (Boehringer Mannheim
127426) pH 7.5 containing 0.1 mol/1 KC1 (Merck 4936).
Dithioerythritol (Merck 24511; 1 mmol/l): 1.54 mg dithio-
erythritol were dissolved in 10 ml H 2 bidist.
Inosine-5'-monophosphate (Boehringer Mannheim 106704;
40 mmol/1): 5 mg were dissolved in 0.25 mi 0.1 mol/1 triethanol-
amine buffer pH 7.5 containing 0.1 mol/1 KC1.
Adenosine-5'-monophosphate (Boehringer Mannheim 102199;
40 mmol/1): 5 mg were dissolved in 0.25 ml 0.1 mol/1 tri-
ethanolamine buffer pH 7.5 containing 0.1 mol/1 KC1.
Buffer-mixture
To a mixture of 9 ml 0.1 moi/i triethariolamine buffer pH 7.5
containing 0.1 mol/1 KC1 and 1 ml ethanol (Merck 972) were
added 0.01 ml catalase suspension (EC 1.11.1.6; Boehringer
Mannheim 106 810; 10 mg/ml; ca. 13000 U) 5 mg NADP,
135 mg glycerol-2-phosphate (disodium salt), 0.02 ml of
1 mol/1 potassium dihydrogenphosphate (Merck 4873) and
0.1 ml of 1 mol/1 magnesium chloride (Merck 5833). pH was
readjusted to 7.5.
Enzymes
Aldehyde dehydrogenase (EC 1.2.1.5; Sigma A-6758): 10 mg
of the lyophilized powder (ca. 5 mg protein) were dissolved in
1 ml H20 (ca. 50 U/mi). If necessary to remove phosphate, the
enzyme was dissolved in 0.1 mol/1 triethanolamine buffer
pH 7.5 containing 0,1 mol/1 KC1 and glycerol 3 mol/1 and
dialyzed overnight at 4 °C against the same solution. The
dialyzed enzyme was stable for one week at 4 °C.
Xanthine oxidase (EC 1.2.3.2; Boehringer Mannheim 110442;
10 mg/ml; ca. 0.4 U/mg): For elimination of (NH4)2SO4, which
produces magnesium ammonium phosphate precipitation, the
enzyme suspension was dialyzed overnight at 4 °C against
O.J mol/l KC1. The dialyzed enzyme showed an activity of about
3 U/ml and was stable for one week at 4 °C.
Reaction (4) and (5) were described originally for the
determination of uric acid in human serum (30, 31) and
2) A^^(w-bromophenyl)-5,6Adihydroimidazo(2,l-b)thiazole
oxalate.
J. Clin. Chem. Clin. Biochem. / Vol. 18,1980 /No. 11
Heinz, Pilz, Reckel, Kalden and Haeckel: Determination of 5'-nucleotidase 783
Nucleoside phosphorylase (EC 2.4.2.1; Boehringer Mannheim
107964; 5 mg/ml; ca. 20 U/mg): If necessary, the enzyme
suspension was dialyzed phosphate-free overnight at 4 °C
against 0.1 moi/1 triethanolamine buffer containing 0.1 mol/1
KC1 and glycerol 3 mol/1 (stable for ten days at 4 °C).
Adenosine deaminase (EC 3.5.4.2; Boehringer Mannheim
102121; 10mg/ml; 200 U/mg): The suspension was used with-
out further dilution.
Antibodies
NaCl-polyethyleneglycol-solution: 0.15 mol/1 NaCl containing
6%polyethyleneglycol 6000 (Serva 33137).
Anti-alkaline phosphatase from liver/bone (Merck 13 772):
10 mg lyophilized powder were dissolved in 1 ml NaCl-poly-
ethyleneglycol solution.
Instrumentation
In the manual versions, the NAD(P)H reduction rates were
measured in an Eppendorf photometer at Hg 334 nm at 30 °C.
The change in absorbance was registered continuously. The
mechanized version was performed with a Gemsaec analyzer
(ElectroNucleonics, Stuttgart).
The determination of alkaline phosphatase activity was
performed with an. Eppendorf photometer at Hg 405 nm. The
absorbance at 690 nm, used for the determination of phos-
phate in the test system according to Campbell (11) and Rieder
(10), was measured with a spectrophotometer Zeiss PMQ-II.
Methods
5'-Nucleotidase
For optimisation experiments, the reagents listed in table 1
were pipetted into a semimicro-cuvette with 10 mm optical
path-length, thoroughly mixed, and incubated for 15 minutes
at 30 °C. During this time, the reaction temperature was
reached and traces of acetaldehyde present in the ethanol were
dehydrogenated. Then a small linear rise of absorbance was
registered at 334 nm, which represents the blank and has to be
subtracted. The reaction was started by the addition of 5'-IMP.
After a lag period of one to three minutes, depending on the
5'-nucleotidase activity, a linear rise of absorbance for at least
10 minutes was observed.
If one of the components was varied, a calculated volume of a
stock solution was added to the mixture lacking this particular
component. Thus, manganese replaced the magnesium ion,
R 8231 the glycerol-2-phosphate, and NAD replaced NADP or
was added additionally.
For routine application in clinical chemistry in the manual and
mechanical version, dithioerythritol, which stabilizes the al-
dehyde dehydrogenase, was omitted and EDTA was added. In
this case, the magnesium concentration had to be elevated. For
simplification, the enzymes were added to the buffer mixture.
The test composition, shown in table 2, is stable for 6 h in an
ice bath.
Alkaline phosphatase
Alkaline phosphatase was measured using the test kit "alk.
Phosph. opt." from Boehringer Mannheim (123 862), but the
reaction temperature was kept at 30 °C.
Precipitation of alkaline phosphatase by antibodies
0.5 ml serum were incubated with 0.025 ml dissolved antibodies
(sufficient for at least l U alkaline phosphatase) and 0.475 ml
NaCl-polyethyleneglyc l-s lution for l h at 37 C and then
stored for 16-18 h at 4 °C. After centrifugation, the super-
natant was tested for alkaline phosphatase activity. For the
control, 0.5 ml of the same serum were mixed with 0.5 ml
NaQ-polyethyleneglycol solution and treated identically.
Absorption coefficients
For NADPH, the molar absorption coefficient (6334
 nm) of
6.18 Χ 1Ό2 (1 · moF1 · mm"1) and for p-nitrophenol (e40s nm)
Tab. 1. Reaction mixture for optimisation-experiments.
Reagents μΐ Concentration Activities
in the assay under
present
condi-
tions
Buffer-reagent-mixture:
9 ml 0.1 mol/1 0.09 mol/1
triethanolamine, pH 7.5,
containing 0.1 mol/1 KC1 0.09 mol/1
1ml ethanol 1.7 mol/l
0.01 ml catalase 13 000 U
(10 mg/ml)
5 mg NADP 400 0.64 mmol/1
135 mg glycerol-2- 0.043 mol/1
phosphate, disodium salt
0.02 ml potassium 0.002 mol/1
phosphate (1 mol/1)
0.1 ml magnesium 0.01 mol/1
chloride (1 mol/1)
Dithioerythritol 5 0.01 mmol/1
(1 mmol/1)
Aldehyde dehydrogenase 25 0.3 U
(10 mg/ml)
Xanthine oxidase 40 0.1 U
(10 mg/ml, dialyzed)
Nucleoside phosphorylase 5 0.25 U
(5 mg/ml)
Sample 50
Incubate for 15 min, after registration of the blank, start with
Inosine-5'-monophosphate 5 0.4 mmol/1
(0.04 mol/1)
of 18.5 Χ ΙΟ2 (ΙτηοΓ
were used.
• mm"1) according to Walter et al (35)
Enzyme units
The enzyme activities are expressed in international units (U).
l U 5'-nucleotidase represents the disappearance of 1 μιηοίε of
5'-IMP, and l U of alkaline phosphatase the splitting of 1 μπιοΐβ
of p-nitrophenylphosphate per minute at 30 °C. For comparison
with our method, a commercially available test kit (5'-nucleotidase,
Biomerieux 6-1251 and 6-1261) was used. The determination
and calculation were carried out according to the manufacturer.
Results and Discussion
Choice of substrates
In general, 5'-AMP is used as a substrate for 5'-nucleotid-
ase. We prefer 5'-IMP at a final concentration of
0.4 mmol/1, because the same Km -values of 0.03 mmol/1
were found for S'-IMP and 5'-AMP, and the maximal
velocities were also identical. However, in the case of
5'-AMP, an extra 2 U of adenosine deaminase had to be
added to the test system.
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Tab. 2. Reaction mixture for the manual and mechanized version
in routine application.
Reagents μΐ Concentration Activities
in the assay under
present
condir
tions
Buffer-reagen t-m ix ture:
9 ml 0.1 mol/1
triethanolamine, pH 7.5,
containing 0.1 mol/1 KC1
and 1 mmol/1 EDTA
1 ml ethanol
0.01 ml catalase
(10mg/ml)
5 mg NADP
135 mg glycerol-2-
phosphate, disodium salt
0.02 ml potassium
phosphate (1 mol/1)
0.15 ml magnesium
chloride (1 mol/1)
7 mg aldehyde
dehydrogenase
0.14 ml nucleoside
phosphorylase (5 mg/ml)
1 ml xanthine oxidase
(10 mg/ml), dialyzed
overnight against
0.1 mol/1 KC1
'Sample
Start with
Inosine-5'-mono-
phosphate (0.04 mol/1)
Respectively blank with
Water
450
0.09 mol/1
0.09 mol/1
0.9 mmol/1
1.7 mol/1
0.64 mol/1
0.043 mol/1
0.002 mol/1
0.015 mol/1
13 000 U
0.3 U
0.1 U
0.25
150
0.4 mmol/1
pH-optimum
The optimal pH, reported by most authors between 7.2
and 7.9 (11,13,23,25,27) was found to be 7.5 in our
assay with a plateau of activity between 7.25 and 7.75.
Influence of phosphate
For optimisation, it was necessary to establish the in-
fluence of phosphate; purine nucleoside phosphorylase
needs phosphate as a substrate, whereas phosphate
inhibits 5'-nucleotidase.
The results shown in figure 1 demonstrate that S'-nucleo-
tidase present in a constant volume of serum is not in-
hibited by up to 5 mmol/1 phosphate. At a concentration
of 3 mfnol/i phosphate, the nucleoside phosphorylase
possesses 50% of the normal activity. For this reason, a
total of 3 mmol/1 phosphate was chosen, so that even in
the case of elevated phosphate levels in sera or tissue
extracts, 5'^nucleotidase would not be inhibited.
Choice of the coenzyme
The potassium-dependent aldehyde dehydrogenase from
yeast accepts NAD and NADP as coenzymes.
According to Ellis et al (26), the NADH-dependent test
system with glutamate dehydrogenase gives only 65%
of the activity obtained by measurement at 265 nm
(18). We therefore examined the influence of NAD,
NADP, NADH and NADPH.
Figure 2 shows the dependence of the 5'-nucleotidase
activity on NAD and NADP, when the coenzymes were
added separately. NADP-conceritrations from 0.63 mmol/1
to 1.89 mmol/1 do not influence the S'-nucleotidase
activity, whereas increasing amounts of NAD from
0.11 mmol/l to 2.25 mmol/l cause increasing inhibition.
If NAD, NADH or NADPH were added to the NADP-
coritaining test system, only NAD and NADH were
found to be inhibitors.
Ξ 20
10
0 1 10 100
Phosphate [mmol/l]
Fig. 1. Influence of phosphate on the activity of S'-nucleotidase.
Known amounts of phosphate were added to the test
system of table 1. The activity of nucleoside phosphoryl·
ase, even in the samples with the lowest phosphate con-
tent, was not rate limiting.
OD4
l
NAQP
ΝΑΟ
1
ΝΑΟ (Ρ) [mmol/l]
2
Fig. 2. Influence of NAD and NADP on the activity of S'-nu-
cleotidase.
Different amounts of NAD and NADP were added to
the test system of table 1.
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As in the assay for nucleoside phosphorylase, based on
the same test principle (34), no differences between
NAD and NADP is observed, the decrease of activity
in the S'-nucleotidase assay is not due to an inhibition
of the indicator enzymes.
Influence of divalent cations
The activity of S'-nucleotidase is dependent on divalent
cations. Manganese and magnesium are reported to be
the best activators (16, 27,36).
With magnesium ions a plateau of maximal activity is
reached at concentrations higher than 10 mmol/1.
Manganese is even more effective and would increase the
sensitivity of our method, but difficulties occur with
the low solubility of manganese phosphate. To introduce
manganese in concentrations up to the optimum of
1 mmol/1, it is necessary to lower the phosphate con*
centration to 0.1 mmol/1. In this case, all indicator
enzymes have to be dialyzed phosphate-free and the
amount of nucleoside phosphorylase has to be increased
six-fold for the same test capacity.
The manganese method cannot be recommended for
the determination of S'-nucleotidase in sera, as the
sensitivity with magnesium is high enough even in sera
of healthy persons. However, it is necessary for the deter-
mination of 5'-nucleotidase in lymphocyte extracts
(37).
Prevention of 5'-IMP hydrolysis
by unspecific phosphatases
One of the critical points in the determination of
S'-nucleotidase activity is the unspecific splitting of
micleoside-5'-monophosphates, which is reported to be
caused by alkaline phosphatase present in sera and
tissue extracts. Several methods have been described to
bypass this difficulty.
S'-nucleotidase may be inhibited by nickel ions (10, 11,
15), concanavalin A (22, 23) or ,/3-methylene-
adenqsine-S'-diphosphate (6), and the activity may be
calculated by the difference in the presence arid absence
of the inhibitor. The use of nickel ions äs a "specific"
inhibitor for S'-nucleotidase has already been criticized
by several authors (5,14,16), because the activity of
alkaline phosphatäse from serum (14) and human bone
(38) was found to be considerably effected by nickel
ions. The same is said for a,j3-methyleneadenQsine-5'-
diphosphate (23). M our hands, the addition of con-
canavalin A to our test system containing the serum
sample caused a precipitate probably due to glyco-
pföteins and was not suitable for a spectrophotometric
assay.
Alternatively, the activity of alkaline phosphatase may
be inhibited by L-amino acids such as Z,-histidine (36,
38,39), i-cysteine (14,39) orZ,-glycine (7,40). The
influecne of amino acids is obscure, as detailed studies
have only been described for bull seminal plasma (36
38).
Another possibility for the elimination of nucleoside-5'-
monophosphate hydrolysis is the simultaneous deter-
mination of alkaline phosphatase at pH 7.5 with 2'-AMP
and 3;-AMP as substrates, or at pH 9.8 withp-nitro-
phenylphosphate, from which the interference of
alkaline phosphatase with the S'-nucleotidase assay can
be calculated using an empirical correction factor (16).
Furthermore, the technique of "enzyme diversion"
according to Belfield & Goldberg (41) may be applied
where high concentrations of glycerol-2-phosphate are
offered to the alkaline phosphatase resulting in a com-
petitive displacement of the nucleoside-5'-monophos-
phate from the active center; phenylphosphate may
substitute for glycerol-2-phosphate (11), but there is no
advantage (41). Among these possibilities, we chose
first the technique of "enzyme diversion". Figure 3
shows some typical results with a serum of a patient
suffering from liver disease. Identical figures were
obtained with sera of patients suffering from bone
diseases with high osteoblastic activity.
Our results agree well with the findings of Belfield et
al. (19,41, 42) and Ellis et al. (26). For further experi-
ments, we chose a concentration of 43 mmol/1 glycerol-
2-phosphate, corresponding to a 100-fold excess over
5'-IMP.
The phosphate production from glycerol-2-phosphate
by unspecific phosphatases during the incubation
period and during the test time, which might have an
inhibitory effect on S'-nucleotidase (see figure 1), is
negligible. According toBeckman et al. (16) we can
estimate the phosphate production by a 100
sample of pathologic serum containing 1000 U/l
alkaline phosphatase at 50 nmol/1 phosphate after
15 minutes.
JL _L
0 20 60 100
Glycerol-2-phosphate (mmol/U
Fig. 3. Inhibition of unspecific phosphatase activity by glycerol-
2-phosphate.
Known amounts of glycerol-2-phosphate were added to
the test system of table 1, which contains a serum sample
with high activity of alkaline phosphatase.
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The commercial availability of sheep antibodies against
human alkaline phosphatase from liver and bone offers
the possibility of a specific elimination of the inter-
fering alkaline phosphatase. By treatment of sera con-
taining high activities of alkaline phosphatase with
antibodies, the activity was reduced to 1-20%. Table 3
shows the results for a selection of sera. Of course, the
treatment with antibodies reduces the unspecific
hydrolysis of S'-IMP at pH 7.5. However, the addition
of glycerol-2-phosphate to antibody-treated sera reduces
the hydrolysis even further, an effect, which could no
longer be explained by the small residual activity of
alkaline phosphatase. In the presence of glycerol-2-
phosphate, 5'-IMP hydrolysis was nearly identical in
antibody-treated and untreated sera.
A new possibility for the very specific and effective
inhibition of alkaline phosphatase is the application of
the anthelmintic levamisole analogue R 8231 (43,44).
With R 8231 in a concentration of 3 mmol/1, we could
block the alkaline phosphatase activity at pH 9.8 in
sera almost completely (99%). In our test system, we
found a reduction of total 5'-IMP hydrolysis at pH 7.5
with R 8231 corresponding well to the diminution of
5'-IMP hydrolysis after antibody elimination of alkaline
phosphatase.
From the data cited above, we assume that the un-
specific 5'-IMP hydrolysis at pH 7.5 is not only caused
by alkaline phosphatase, but may be due to other phos-
phatases, e.g. acid prostatic phosphatase, present in
sera, the activity of which was eliminated by glycerol-2-
phosphate. For this reason, we prefer the technique
of "enzyme diversion" with glycerol-2-phosphate.
Tab. 4. The within-run imprecision of the determination of the
catalytic 5'-nucleotidase activity (n * 10).
I
(sample
blank)
Manual procedure
Mean value (U/l)
Standard deviation (U/l)
CV2) (%)
Mean value (U/l)
Standard deviation (U/l)
CV(%)
0.92
0.45
48.6
0.14
0.31
22.1
Π1)
(1 +
substrate)
12.8
0.85
6.6
3.05
0.30
9.7
Mechanized procedure (Gemsaec)
Mean value (U/l)
Standard deviation (U/l)
CV(%)
Mean value (U/l)
Standard deviation (U/l)
CV(%)
1.48
0.11
7.6
0.39
0.11
28.2
12.75
0.38
3.0
3.25
0.11
3.3
1) Individual sample blank subtracted
2) CV, coefficient of variation
Precision '
Several series of ten determinations were performed
with human serum samples manually and with a
Gemsaec analyzer. The coefficient of variation varied
between 3.0 and 9.7% (tab. 4).
Detection limit
The minimal enzyme activity detectable with our
method is 0.05 U in a cuvette volume of 0.6 ml cor-
responding to 0.24 U/l sample if 0.2 ml of sample was
added.
Tab. 3. Influence of glycerol-2-phosphate before and after treat-
ment of sera with anti-alkaline phosphatase from liver/
bone.
Activities
(U/l)
Alkaline phosphatase
before antibodies
Alkaline phosphatase
after antibodies
Difference
5'-Nucleotidase
before antibodies
Without glycerol-2-P
Glycerol-2-P added
Difference ± glycerol-2-P
5'-Nucleotidase
after antibodies
Without glycerol-2-P
Glycerol-2-P added
Difference ± glycerol-2-P
1300
10
1290
6.4
4.8
1.6
5.2
4.8
0.4
280
48
232
10.2
9.5
0.7
9.8
9.3
0.5
3500
126
3374
40.3
36.'8*
3.5
37.6
37.2
0.4
1075
5
1070
2.0
0.5
1.5
0.5
0.4
0.1
Linearity
Figure 5 shows a linear correlation between the amount
of sample added and the change of absorbance up to
0.04 ΔΑ/min.
0.04
c
*e
1(102
50 100
Serum. [/U<]
150
Fig. 4. Dependence of the absorbance change per minute at
334 nm on the amount of 5'^nucieotidase added.
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Comparison of methods
For comparison, we chose a commercially available
test kit from Biomerieux, Nürtingen, which uses the
liberation of phosphate from 5'-AMP as an indicator for
S'-nucleotidase activity. The 5'-nucleotidase activity
is calculated from the amount of phosphate liberated
in the presence and absence of nickel ions (tab. 5).
The correlation between our method and the commer-
cially available method was examined by means of
linear regression analysis; the resulting coefficient value
of r = 0.88 (n = 6) indicated a poor correlation.
Tab. 5. Comparison of our method with a commercially
available test kit, using the liberation of phosphate from
5'-AMP in the presence and absence of nickel ions
according to Campbell (11) and Rieder (10).
Serum 5'-Nucleotidase
(U/l)
activity
Determined with Determined with the
1
2
3
4
5
6
our method
1.89
2.27
2.89
2.60
1.47
1.89
commercially
available method
8.56
11.73
12.29
10.42
5.40
5.77
The high values obtained for 5'-nucleotidase with the
assay according to Campbell (11) and Rieder (10) may
have several causes. One reason may be the higher
temperature in the commercially available method
(37 °C) compared with ours (30 °C).
Furthermore, not only 5'-nucleotidase, but alkaline
phosphatase (14, 16) as well as other unspecific phos-
phatases, which are not yet well characterized, may be
inhibited by nickel ions. In this way, the activity of
alkaline phosphatase and unspecific phosphatases is
diminished. An additional decrease of colour develop-
ment is found in the presence of nickel ions, because
of precipitation or complex-binding of phosphate by
Ni2*; this is not controlled by an appropriate blank
containing nickel but no sample.
Clinical application and reference values will be reported
separately.
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